PharmacoEconomics - open
Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality.
Arendse Tange Larsen, Liza Sopina, Eske Kvanner Aasvang, Christian S Meyhoff, Søren Rud Kristensen, Jakob Kjellberg
Published: 202610.1007/s41669-025-00632-9
Abstract
BACKGROUND/OBJECTIVE: Hospital-level care at home is gaining traction, but evidence on health economic implications remains limited. The aim of this study was to estimate expected costs of continuous remote monitoring of vital signs in the post-disch…
Preview only. Read the full abstract at the source